Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aveo Pharmaceuticals Inc (NASDAQ:AVEO)

1.95
Delayed Data
As of Jun 26
 +0.70 / +56.00%
Today’s Change
0.50
Today|||52-Week Range
2.11
+261.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues193.0K992.0K127.0K2.5M
 
 
 
 
 
Depreciation And Amortization2.0K0.0023.0K0.00
 
 
 
 
Operating ExpensesGross Income----------
General Expenses7.3M6.6M9.5M10.3M
 
 
 
 
 
Research And Development5.6M4.4M7.7M8.0M
 
 
 
 
 
Total Operating Expenses7.3M6.6M9.6M10.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.1M-5.6M-9.4M-7.8M
 
 
 
 
 
Extraordinary Credit0.001.2M4.6M0.00
 
 
 
Extraordinary Charge-996.0K0.000.00-484.0K
 
 
 
Interest Expense On Debt468.0K551.0K561.0K551.0K
 
 
 
 
 
Other Expenses0.000.00-187.0K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.6M-5.0M-5.6M-8.8M
 
 
 
 
 
Income Taxes0.000.000.00-50.0K
 
 
Net Income-8.6M-5.0M-5.6M-8.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS66.9M75.9M75.9M76.2M
 
 
 
 
 
Shares To Calculate EPS Diluted66.9M75.9M75.9M76.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.13-$0.07-$0.07-$0.12
 
 
 
 
 
EPS Diluted-$0.13-$0.07-$0.07-$0.12